Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
130 participants
OBSERVATIONAL
2022-02-01
2022-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Value of Fetal Scalp Lactate Sampling During Labour in Cases of Abnormal Fetal Heart Rate
NCT05259202
Antenatal Corticosteroid Therapy: Which Impact on Birth Parameters?
NCT05640596
Magnesium Sulfate (MgSO4) and Fetal Heart Rate (FHR) in Case of Prematurity
NCT03956121
Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-be
NCT01322529
Uterocervical Angle in Prediction of Preterm Labor
NCT05632003
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
pH < 3
Patients one or two fetal blood sampling
Fetal blood sampling
Fetal scalp blood sampling and analysis
pH > 3
Patients with three or more fetal blood sampling
Fetal blood sampling
Fetal scalp blood sampling and analysis
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Fetal blood sampling
Fetal scalp blood sampling and analysis
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Singleton pregnancy
* Gestational age equal or above 37 weeks
* No contra-indication of fetal blood sampling
* No pregnancy complication
Exclusion Criteria
* Incomplete file
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Central Hospital, Nancy, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
TOURNIER Mathilde
Resident, Obstetrics and Gynecology, Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Regional University Maternity of Nancy
Nancy, Meurthe-et-Moselle, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023PI036
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.